Abbott (ABT) Reports Q4 EPS of $0.05
Tweet
Share
E-mail
Get Alerts ABT Hot Sheet
Price: $103.36 -1.78%
Revenue Growth %: +14.2%
Financial Fact:
Total Operating Cost and Expenses: 4.41B
Today's EPS Names:
VIVO, BIOX, PMCB, More
Revenue Growth %: +14.2%
Financial Fact:
Total Operating Cost and Expenses: 4.41B
Today's EPS Names:
VIVO, BIOX, PMCB, More
Join SI Premium – FREE
Abbott (NYSE: ABT) reported Q4 EPS of $0.05, versus $0.03 reported last year. Revenue for the quarter came in at $6.17 billion versus the consensus estimate of $6.71 billion.
For earnings history and earnings-related data on Abbott (ABT) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Oracle (ORCL) Tops Q1 EPS by 19c, Beats on Revenue; Beats on Cloud Revenue, Offers Q3 EPS Guidance
- Frequency Electronics (FEIM) Tops Q1 EPS by 12c
- Copart (CPRT) Misses Q4 EPS by 4c
Create E-mail Alert Related Categories
Earnings, GuidanceRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
